Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Koivumäki JT"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
Computational cardiac physiology for new modelers: Origins, foundations, and future.
Autorzy:
Koivumäki JT; Faculty of Medicine and Health Technology, and Centre of Excellence in Body-on-Chip Research, Tampere University, Tampere, Finland.
Hoffman J; Division of Computational Science and Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
Maleckar MM; Computational Physiology Department, Simula Research Laboratory, Oslo, Norway.
Einevoll GT; Centre for Integrative Neuroplasticity, University of Oslo, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway.; Department of Physics, Norwegian University of Life Sciences, Ås, Norway.
Sundnes J; Computational Physiology Department, Simula Research Laboratory, Oslo, Norway.
Pokaż więcej
Źródło:
Acta physiologica (Oxford, England) [Acta Physiol (Oxf)] 2022 Oct; Vol. 236 (2), pp. e13865. Date of Electronic Publication: 2022 Aug 25.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiovascular Physiological Phenomena*
Models, Theoretical*
Models, Biological ; Research Design
Czasopismo naukowe
Tytuł:
Regulation of APD and Force by the Na Exchanger in Human-Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue.
Autorzy:
Ismaili D; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Gurr K; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Horváth A; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Yuan L; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.; Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Lemoine MD; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Schulz C; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Sani J; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Petersen J; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.; Department of Cardiovascular Surgery, University Heart and Vascular Center, 20246 Hamburg, Germany.
Reichenspurner H; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.; Department of Cardiovascular Surgery, University Heart and Vascular Center, 20246 Hamburg, Germany.
Kirchhof P; Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Jespersen T; Department of Cardiovascular Surgery, University Heart and Vascular Center, 20246 Hamburg, Germany.
Eschenhagen T; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Hansen A; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Koivumäki JT; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Christ T; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Aug 05; Vol. 11 (15). Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Induced Pluripotent Stem Cells*/metabolism
Action Potentials ; Adult ; Animals ; Heart Ventricles/metabolism ; Humans ; Myocytes, Cardiac/metabolism ; Rats ; Sodium-Calcium Exchanger/metabolism
Czasopismo naukowe
Tytuł:
A mathematical model of hiPSC cardiomyocytes electromechanics.
Autorzy:
Forouzandehmehr M; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Koivumäki JT; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Hyttinen J; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Paci M; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Pokaż więcej
Źródło:
Physiological reports [Physiol Rep] 2021 Nov; Vol. 9 (22), pp. e15124.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Action Potentials/*physiology
Electrophysiological Phenomena/*physiology
Induced Pluripotent Stem Cells/*physiology
Myocardial Contraction/*physiology
Myocytes, Cardiac/*physiology
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology ; Action Potentials/drug effects ; Calcium Channel Agonists/pharmacology ; Calcium Channel Blockers/pharmacology ; Computer Simulation ; Electrophysiological Phenomena/drug effects ; Humans ; Models, Theoretical ; Myocardial Contraction/drug effects ; Myocytes, Cardiac/drug effects ; Verapamil/pharmacology
Czasopismo naukowe
Tytuł:
hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single Cells.
Autorzy:
Shah D; Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, Tampere 33520, Finland.
Prajapati C; Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, Tampere 33520, Finland.
Penttinen K; Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, Tampere 33520, Finland.
Cherian RM; Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, Tampere 33520, Finland.
Koivumäki JT; Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, Tampere 33520, Finland.
Alexanova A; Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, Tampere 33520, Finland.
Hyttinen J; Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, Tampere 33520, Finland.
Aalto-Setälä K; Faculty of Medicine and Health Technology and BioMediTech Institute, Tampere University, Tampere 33520, Finland.; Heart Hospital, Tampere University Hospital, Tampere 33520, Finland.
Pokaż więcej
Źródło:
Cells [Cells] 2020 May 07; Vol. 9 (5). Date of Electronic Publication: 2020 May 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Models, Biological*
Induced Pluripotent Stem Cells/*pathology
Long QT Syndrome/*genetics
Long QT Syndrome/*pathology
Mutation/*genetics
Myocytes, Cardiac/*pathology
Adult ; Alleles ; Case-Control Studies ; Cell Aggregation ; Female ; Humans ; Induced Pluripotent Stem Cells/metabolism ; Ion Channel Gating ; Male ; Middle Aged ; Myocytes, Cardiac/metabolism
Czasopismo naukowe
Tytuł:
Case Report on: Very Early Afterdepolarizations in HiPSC-Cardiomyocytes-An Artifact by Big Conductance Calcium Activated Potassium Current (I bk,Ca ).
Autorzy:
Horváth A; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, 6721 Szeged, Hungary.
Christ T; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Koivumäki JT; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
Prondzynski M; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Zech ATL; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Spohn M; Bioinformatics Core, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Saleem U; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Mannhardt I; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Ulmer B; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Girdauskas E; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.; Department of Cardiovascular Surgery, University Heart Center, 20246 Hamburg, Germany.
Meyer C; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, 6721 Szeged, Hungary.; Department of Cardiology-Electrophysiology, University Heart Center, 20246 Hamburg, Germany.
Hansen A; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Eschenhagen T; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Lemoine MD; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.; Department of Cardiology-Electrophysiology, University Heart Center, 20246 Hamburg, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2020 Jan 20; Vol. 9 (1). Date of Electronic Publication: 2020 Jan 20.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Action Potentials*/physiology
Artifacts*
Induced Pluripotent Stem Cells/*metabolism
Myocytes, Cardiac/*metabolism
Potassium Channels, Calcium-Activated/*metabolism
Adult ; Cell Line ; Computer Simulation ; Humans ; Peptides/toxicity ; Tissue Engineering
Czasopismo naukowe
Tytuł:
Ca(2+) -activated K(+) current is essential for maintaining excitability and gene transcription in early embryonic cardiomyocytes.
Autorzy:
Karppinen S; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Rapila R; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Naumenko N; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Tuomainen T; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Koivumäki JT; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Hänninen SL; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.; Institute of Biomedicine, Department of Physiology and Biocenter Oulu, University of Oulu, Oulu, Finland.
Korhonen T; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Tavi P; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Pokaż więcej
Źródło:
Acta physiologica (Oxford, England) [Acta Physiol (Oxf)] 2016 Jan; Vol. 216 (1), pp. 101-11. Date of Electronic Publication: 2015 Jun 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Calcium/*metabolism
Calcium Signaling/*physiology
Membrane Potentials/*physiology
Myocytes, Cardiac/*cytology
Myocytes, Cardiac/*metabolism
Potassium/*metabolism
Sarcoplasmic Reticulum/*metabolism
Animals ; Apamin/metabolism ; Female ; Mice ; Muscle, Smooth/metabolism ; Pregnancy ; Transcription, Genetic
Czasopismo naukowe
Tytuł:
In silico screening of the key cellular remodeling targets in chronic atrial fibrillation.
Autorzy:
Koivumäki JT; Simula Research Laboratory, Center for Cardiological Innovation and Center for Biomedical Computing, Oslo, Norway; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Seemann G; Institute of Biomedical Engineering, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Maleckar MM; Simula Research Laboratory, Center for Cardiological Innovation and Center for Biomedical Computing, Oslo, Norway.
Tavi P; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2014 May 22; Vol. 10 (5), pp. e1003620. Date of Electronic Publication: 2014 May 22 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Models, Cardiovascular*
Action Potentials/*physiology
Atrial Fibrillation/*physiopathology
Calcium Signaling/*physiology
Heart Atria/*physiopathology
Heart Conduction System/*physiopathology
Myocytes, Cardiac/*physiology
Atrial Remodeling ; Calcium/metabolism ; Calcium Channels/physiology ; Cells, Cultured ; Computer Simulation ; Heart Atria/pathology ; Heart Conduction System/pathology ; Humans ; Ion Channel Gating/physiology
Czasopismo naukowe
Tytuł:
Impact of sarcoplasmic reticulum calcium release on calcium dynamics and action potential morphology in human atrial myocytes: a computational study.
Autorzy:
Koivumäki JT; Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Korhonen T
Tavi P
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2011 Jan 27; Vol. 7 (1), pp. e1001067. Date of Electronic Publication: 2011 Jan 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Action Potentials*
Calcium/*metabolism
Heart Atria/*metabolism
Sarcoplasmic Reticulum/*metabolism
Diffusion ; Heart Atria/cytology ; Humans
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies